Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil - WF 97116

This study is to compare the safety and effects of donepezil (Aricept) or if it decreases memory loss after receiving chemotherapy for breast cancer.

Research Base: Wake Forest University Health Sciences
NCT ID: NCT02822573
NCI Protocol Number: WF-97116
Status: Recruiting

For more information see ClinicalTrials.gov

Interventions

Donepezil 5 mg; Placebo

Condition

Cognitive Dysfunction, Memory Impairment

Trial Type

Supportive Care/Symptom Management/PROs

See a list of participating sites on ClinicalTrials.gov


˄
BACK TO
TOP